• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS PUMP MODULE SMARTSITE INFUSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS PUMP MODULE SMARTSITE INFUSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 2426-0007
Device Problem Connection Problem (2900)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/15/2024
Event Type  malfunction  
Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event Description
It was reported that bd alaris pump module smartsite infusion set separated the following information was received by the initial reporter with the following verbatim.Rcc received a complaint via email.Email(s) attached.Alaris pump tubing sku# (b)(4).The tubing came out of the end of the port.To be safe they had to take the rest of the lot (13 cases) off of their shelf.Now they are short of those cases and need to reorder more.(b)(4).
 
Event Description
No additional info.
 
Manufacturer Narrative
It was reported that the tubing was defective.One sample model 2426-0007, lot 23119289 was returned for investigation.The set was examined for defects and abnormalities.The tubing was separated from the ysite.No other defects or abnormalities were observed.Upon visual inspection under the microscope, an absence of solvent was observed.The customer complaint was verified and a quality notification was sent to the manufacturer.From the manufacturer's investigation, the possible root cause is due to incorrect solvent application by the assembler.A quality alert was created on april 02nd, 2024 to communicate the problem, reinforce the correct solvent application method and avoid the lack of solvent.A device history record review for model 2426-0007 lot number 23119289 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 04jan2024.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.H3 other text : see h10 below.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS PUMP MODULE SMARTSITE INFUSION SET
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key18891870
MDR Text Key337775715
Report Number9616066-2024-00418
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403227998
UDI-Public(01)10885403227998
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K221327
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number2426-0007
Device Lot Number23119289
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/22/2024
Initial Date FDA Received03/13/2024
Supplement Dates Manufacturer Received04/22/2024
Supplement Dates FDA Received05/01/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/23/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-